Nisa Investment Advisors LLC Grows Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nisa Investment Advisors LLC boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 36,779 shares of the medical instruments supplier’s stock after buying an additional 1,242 shares during the period. Nisa Investment Advisors LLC’s holdings in DENTSPLY SIRONA were worth $1,309,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Arvest Trust Co. N A bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $237,000. International Assets Investment Management LLC bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $782,000. Arizona State Retirement System grew its position in DENTSPLY SIRONA by 2.1% in the 4th quarter. Arizona State Retirement System now owns 59,184 shares of the medical instruments supplier’s stock valued at $2,106,000 after acquiring an additional 1,215 shares during the last quarter. UMB Bank n.a. grew its position in DENTSPLY SIRONA by 0.6% in the 4th quarter. UMB Bank n.a. now owns 74,181 shares of the medical instruments supplier’s stock valued at $2,640,000 after acquiring an additional 473 shares during the last quarter. Finally, DAVENPORT & Co LLC bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $1,220,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Down 2.2 %

DENTSPLY SIRONA stock opened at $31.30 on Monday. The stock has a 50-day moving average of $33.08 and a two-hundred day moving average of $32.95. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. DENTSPLY SIRONA Inc. has a one year low of $26.27 and a one year high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $972.61 million. During the same period last year, the business posted $0.46 earnings per share. The firm’s revenue was up 3.0% compared to the same quarter last year. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. The ex-dividend date was Wednesday, March 27th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 2.04%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -103.22%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on XRAY shares. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Needham & Company LLC reissued a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Barrington Research reissued an “outperform” rating and set a $41.00 price target on shares of DENTSPLY SIRONA in a research report on Friday, March 1st. Finally, SVB Leerink started coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price target on the stock. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.